Beauty Farm Medical and Health Industry Inc. (Beauty Farm) disclosed a share repurchase on 16 June 2026, buying back 60,000 ordinary shares on the Hong Kong Stock Exchange at prices ranging from HK$17.51 to HK$18.09, for a volume-weighted average of HK$17.8406. The aggregate cash outlay was HK$1.07 million.

Following the transaction, Beauty Farm’s outstanding share count fell 0.0241% to 248.84 million, while treasury shares rose to 2.75 million. Total issued shares remained unchanged at 251.59 million.

The repurchase forms part of the mandate approved on 27 June 2025, which authorises the company to buy back up to 23.58 million shares. To date, Beauty Farm has repurchased 2.75 million shares under this mandate, equivalent to 1.17% of the shares outstanding when the authority was granted.

A 30-day moratorium on new share issues or treasury share sales is in effect until 16 July 2026, in line with Hong Kong listing rules. Director Li Yang confirmed that the buyback complied with all regulatory requirements.